Bryan Meyers

Medicine & Life Sciences

1. Lung Transplantation 100%
2. Non-Small Cell Lung Carcinoma 93%
3. Lung 73%
4. Lung Neoplasms 65%
5. Survival 53%
6. Emphysema 46%
7. Pneumonectomy 44%
8. Esophageal Neoplasms 35%
9. Video-Assisted Thoracic Surgery 35%
10. Bronchiolitis Obliterans 34%
11. Surgeons 33%
12. Esophagectomy 31%
13. Thorax 31%
14. Tissue Donors 25%
15. Transplants 24%
16. Neoplasms 24%
17. Thoracic Surgery 23%
18. Primary Graft Dysfunction 22%
19. Radiosurgery 21%
20. Mortality 19%
21. Lymph Nodes 18%
22. Thoracotomy 16%
23. Positron-Emission Tomography 16%
24. Databases 15%
25. Allografts 15%
26. Recurrence 14%
27. Transplantation 14%
28. Therapeutics 14%
29. Odds Ratio 13%
30. Mediastinoscopy 12%
31. Comorbidity 11%
32. Confidence Intervals 11%
33. Cost-Benefit Analysis 11%
34. Tomography 11%
35. Morbidity 11%
36. Radiotherapy 11%
37. Length of Stay 10%
38. Forced Expiratory Volume 10%
39. Costs and Cost Analysis 10%
40. Brachytherapy 9%
41. Early Detection of Cancer 9%
42. Guidelines 9%
43. Neoadjuvant Therapy 9%
44. Neoplasm Metastasis 8%
45. Pulmonary Fibrosis 8%
46. Multicenter Studies 8%
47. Incidence 8%
48. Transplant Recipients 8%
49. HLA Antigens 7%
50. Lung Diseases 7%